期刊文献+

酒石酸美托洛尔原料及其片剂有关物质检查方法研究

Investigation on the determination method of related substances in metoprolol tartrate and metoprolol tartrate tablets
下载PDF
导出
摘要 目的:改进酒石酸美托洛尔现行标准中有关物质的测定方法,为修订和提高标准中的有关物质测定方法提供参考和依据。方法:采用高效液相色谱法,色谱柱为Waters Xbridge C 18(4.6 mm×150 mm,5μm),以醋酸盐缓冲液(取醋酸铵3.9 g,加水810 mL溶解后,加三乙胺2.0 mL,冰醋酸10.0 mL,磷酸3.0 mL,摇匀)为流动相A,乙腈为流动相B,梯度洗脱,流速为2.0 mL·min-1,检测波长为280 nm,柱温为30℃,进样量为20μL;采用线性斜率法计算各杂质校正因子。结果:在拟定的色谱条件下,酒石酸美托洛尔色谱峰与相关杂质完全分离,制剂中的辅料对主成分及有关物质测定无干扰;杂质A^H、杂质J、杂质235和杂质B(USP)的校正因子分别为0.74、0.36、0.048、0.61、1.01、1.47、0.33、0.76、0.99、0.22和0.84;6家企业6批原料的单杂均小于0.049%,杂质总量为0~0.10%;6家企业6批片剂的单杂均小于0.082%,杂质总量为0.0057%~0.23%。结论:改进后的方法更具合理性、准确性和专属性,可用于酒石酸美托洛尔及其片剂有关物质测定。 Objective:To improve the methods of related substances in the current specifications of metoprolol tartrate and metoprolol tartrate tablets and to provide the reference and basis for revision of the determination method of related substances.Method:The test was performed in Waters Xbridge C 18 column(4.6 mm×150 mm,5μm)under the gradient elution of mobile phase A of acetate buffer(take 3.9 g ammonium acetate,add 810 mL water to dissolve,add 2.0 mL triethylamine,10.0 mL glacial acetic acid and 3.0 mL phosphoric acid,then shake well)and mobile phase B of acetonitrile.The flow rate was 2mL·min-1,the detection wavelength was 280 nm,the column temperature was 30℃and the injection volume was 20μL.The relative correction factor of impurities was calculated by linear slope method.Results:Under the proposed chromatographic conditions,the principal component peaks of metoprolol tartrate and peaks of impurities were separated completely,and the excipients in the tablets did not interfere the determination of principal component and impurities.The relative correction factors of specified impurities A^H,J,235 and B(USP)were measured by standard curve method as 0.74,0.36,0.048,0.61,1.01,1.47,0.33,0.76,0.99,0.22 and 0.84 respectively.The individual impurities of six batches of API from six manufacturers all were less than 0.049%,and the total impurities were 0-0.10%.The individual impurities of six batches of tablets from six manufacturers all were less than 0.082%,and the total impurities were 0.0057%-0.23%.Conclusion:The improved method has better specificity and accuracy.It can be applicable to determination of the related substances of metoprolol tartrate and metoprolol tartrate tablets.
作者 严菲 曹玲 李耕 张玫 陈民辉 YAN Fei;CAO Ling;LI Geng;ZHANG Mei;CHEN Minhui(Jiangsu Institute of Food and Drug Control,Nanjing 210019,China;Key Laboratory of chemical impurity spectrum of National Medical Products Administration,Nanjing 210019,China)
出处 《中国药品标准》 CAS 2020年第5期447-454,共8页 Drug Standards of China
基金 重大新药创制科技重大专项《药物一致性评价关键技术与标准研究(2017zx09191001)》。
关键词 酒石酸美托洛尔 片剂 有关物质 高效液相色谱法 校正因子 metoprolol tartrate metoprolol tartrate tablets related substances HPLC relative correction factor
  • 相关文献

参考文献2

二级参考文献22

  • 1ICH Q3A (R2), Impurities in New Drug Substances[ EB/OL]. (2006 - 10-25). [2014 -03 -31]. http://www, ich. org/ LOB/media/MEDIA422. pdf.
  • 2ICH Q3B (R2) Impurities in New Drug Substances [ EB/OL]. (2006 -06-02). [2014 -03 -31]. http://www, ich. org/ LOB/media/MEDIA421. pdf.
  • 3ICH Q3C ( R3 ) Impurities: Guideline for Residual Solvents [EB/OL]. (2005-11). [2014 -03 -31]. http://www, ieh. org/LOB/media/MEDIA423, pdf.
  • 4EMEA. Guideline on the limits of Genotoxic hnpurities [ EB/OL]. (2006 -06 - 28). [2014 -03 -31]. http://www. emea. europa, eu/pdfs/human/swp/519902en, pdf.
  • 5EMEA. Questions & Answers on the CHMP Guideline on the Limits of Genotoxic Impurities, Revision 1 [ S]. (2008 - 06 -26). [2014 -03 -31]. http://www, emea. europa, eu/pdfs/ human/swp/43199407en, pdf.
  • 6FDA. Guidance for Industry Genotoxic and Carcinogenic Impuri- ties in Drug Substances and Products: Recommended Approaches [S]. (2008-11). [2014 -03 -31]. http:// www. fda. gov/ downloads/drugs/guidance complianceregulat-ory information/guidances/ucm079235, pdf.
  • 7ICH. Assessment And Control Of DNA Reactive (Mutagenic) Im- purities In Pharmaceuticals To Limit Potential Carcinogenic Risk[S]. (2013 -02). [2014 -03 -31]. http://www, ieh. org/ product s/guidelines/multi-disciplinary / article/muhidisciplinary- guidelines, html.
  • 8ARIENS E.I. Domestication of chemistry by design of safer chemi- cals: structure-activity relationships[J]. Drug Metab Rev, 1984, 15 ( 3 ) :425 - 504.
  • 9WEISBURGER JH. Environmental Health Perspectives [ J] 1983, 50: 233-245.
  • 10WOO YT. Quantitative Structure-Activity Relationship (QSAR) models of mutagens and carcinogens [ M]. CRC Press: Boca Ra- ton, 2003 : Chapter 2.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部